Moderna/ US60770K1079 /
2024-04-19 8:56:30 PM | Chg. -1.28 | Volume | Bid8:56:53 PM | Ask8:56:53 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
100.74USD | -1.25% | 44,233 Turnover: 4.51 mill. |
100.66Bid Size: 100 | 120.00Ask Size: 105 | 38.5 bill.USD | - | - |
GlobeNewswire
04-04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
03-04
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire
02-29
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire
01-12
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
GlobeNewswire
01-09
PRISM MarketView Honors National Biotechnology Month with a Spotlight on Emerging Biotech Innovators
GlobeNewswire
2023-12-21
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference